{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:40:18Z","timestamp":1742344818016,"version":"3.40.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.aace.2024.12.010","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T17:11:10Z","timestamp":1736269870000},"page":"131-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal Antithyroglobulin Antibody in a Woman With Papillary Thyroid Carcinoma Receiving Intravenous Immunoglobulin Treatment"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-1719","authenticated-orcid":false,"given":"Verdah","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lubitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.aace.2024.12.010_bib1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/thy.2017.0102","article-title":"Updated American Joint Committee on Cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): What changed and why?","volume":"27","author":"Tuttle","year":"2017","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.aace.2024.12.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"Nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.aace.2024.12.010_bib3","first-page":"1121","article-title":"Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma","volume":"83","author":"Spencer","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.aace.2024.12.010_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.aace.2024.12.010_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1172\/JCI114483","article-title":"Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies","volume":"85","author":"Dietrich","year":"1990","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.aace.2024.12.010_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4236\/oji.2014.43010","article-title":"Anti-thyroglobulin IgG in therapeutic immunoglobulins: a reactivity bias in IgG4 subclass","volume":"4","author":"N\u00e9ron","year":"2014","journal-title":"Open J Immunol"},{"issue":"9","key":"10.1016\/j.aace.2024.12.010_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4158\/EP-2020-0053","article-title":"Immunoglobulin preparations can mislead clinical decision-making in follow-up of differentiated thyroid cancer","volume":"26","author":"Y\u00e9l\u00e9h\u00e9-Okouma","year":"2020","journal-title":"Endocr Pract"},{"issue":"12","key":"10.1016\/j.aace.2024.12.010_bib8","article-title":"High thyroglobulin antibody following intravenous immunoglobulin therapy in athyreotic differentiated thyroid cancer patients","volume":"14","author":"Lau","year":"2022","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.aace.2024.12.010_bib9","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.4158\/1934-2403-22.12.1468","article-title":"Thyroglobulin antibodies disappeared after stopping immunoglobulin therapy in a patient with thyroid cancer","volume":"22","author":"Ogrin","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.aace.2024.12.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plabm.2015.11.001","article-title":"Serum sample containing endogenous antibodies interfering with multiple hormone immunoassays. Laboratory strategies to detect interference","volume":"4","author":"Garc\u00eda-Gonz\u00e1lez","year":"2016","journal-title":"Pract Lab Med"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524001512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060524001512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T23:45:24Z","timestamp":1742341524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060524001512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2376060524001512"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2024.12.010","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal Antithyroglobulin Antibody in a Woman With Papillary Thyroid Carcinoma Receiving Intravenous Immunoglobulin Treatment","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2024.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}